Axonics Inc. - רווח נקי למניה אחת בשנים עשר החודשים האחרונים AXNX

The history of net income per share growth YoY ttm reflects the dynamics of Axonics, Inc. (AXNX), where the current level is approximately -548.30. Incontinence treatment solutions are moderately resilient to cycles, although the elective nature of procedures may slow sales during a recession. Insurance reimbursement provides stability, while outsourcing chip production to external foundries minimizes capital expenditures.

Investors must find a balance between operational risks and the actual return on invested capital. Axonics, Inc. (AXNX) dominates the bladder treatment segment thanks to its unique wireless charging technologies. The current annual EPS TTM growth rate measures the net income per share dynamics over a rolling year. This momentum confirms the effectiveness of monetizing its technological advantage over competitors. The steady growth of this metric indicates high business resilience.